Vyne Therapeutics Inc (NASDAQ:VYNE)

2.57
Delayed Data
As of Mar 22
 -0.18 / -6.64%
Today’s Change
1.99
Today|||52-Week Range
14.22
-4.81%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 72.00, with a high estimate of 90.00 and a low estimate of 28.00. The median estimate represents a +2,701.56% increase from the last price of 2.57.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Vyne Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.61
Sales
$0.00
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.12%
 
 
 
 
 
 
Growthannually 77.97%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.